Growth Metrics

Gyre Therapeutics (GYRE) Change in Taxes (2023 - 2026)

Gyre Therapeutics has reported Change in Taxes over the past 3 years, most recently at $261000.0 for Q4 2025.

  • Quarterly Change in Taxes rose 301.54% to $261000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $44000.0 through Dec 2025, up 102.03% year-over-year, with the annual reading at $44000.0 for FY2025, 102.03% up from the prior year.
  • Change in Taxes was $261000.0 for Q4 2025 at Gyre Therapeutics, down from $1.5 million in the prior quarter.
  • Over five years, Change in Taxes peaked at $2.5 million in Q3 2023 and troughed at -$4.2 million in Q2 2024.
  • The 3-year median for Change in Taxes is $387000.0 (2025), against an average of $73416.7.
  • The largest YoY upside for Change in Taxes was 301.54% in 2025 against a maximum downside of 259.24% in 2025.
  • A 3-year view of Change in Taxes shows it stood at -$185000.0 in 2023, then skyrocketed by 135.14% to $65000.0 in 2024, then soared by 301.54% to $261000.0 in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Change in Taxes are $261000.0 (Q4 2025), $1.5 million (Q3 2025), and $513000.0 (Q2 2025).